• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按诊断时的年龄、先证者类型和组织学划分的卵巢癌的家族风险。

Familial risks of ovarian cancer by age at diagnosis, proband type and histology.

机构信息

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

出版信息

PLoS One. 2018 Oct 3;13(10):e0205000. doi: 10.1371/journal.pone.0205000. eCollection 2018.

DOI:10.1371/journal.pone.0205000
PMID:30281663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6169923/
Abstract

Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age at diagnosis and histology are limited. Such data can assist genetic counseling and help elucidate etiologic differences among various histologic types of ovarian malignancies. By using the Swedish Family-Cancer Database, we calculated relative risks (RRs) for detailed family histories using a two-way comparison, which implied e.g. estimation of RRs for overall ovarian cancer when family history was histology-specific ovarian cancer, and conversely, RRs for histology-specific ovarian cancer when family history was overall ovarian cancer. In families of only mother, only sisters or both mother and sisters diagnosed with ovarian cancer, cancer risks for ovary were 2.40, 2.59 and 10.40, respectively; and were higher for cases diagnosed before the age of 50 years. All histological types showed a familial risk in two-way analyses, except mucinous and sex cord-stromal tumors. RRs for concordant histology were found for serous (2.47), endometrioid (3.59) and mucinous ovarian cancers (6.91). Concordant familial risks were highest for mucinous cancer; for others, some discordant associations, such as endometrioid-undifferentiated (9.27) and serous-undifferentiated (4.80), showed the highest RRs. Familial risks are high for early-onset patients and for those with multiple affected relatives. Sharing of different histological types of ovarian cancer is likely an indication of the complexity of the underlying mechanisms.

摘要

卵巢癌是一种异质性疾病。关于特定先证者、诊断时的年龄和组织学的家族风险的数据有限。这些数据可以辅助遗传咨询,并有助于阐明各种卵巢恶性肿瘤组织学类型之间的病因差异。我们使用瑞典家族癌症数据库,通过双向比较计算了详细家族史的相对风险 (RR),例如,当家族史为特定组织学的卵巢癌时,估计总体卵巢癌的 RR,反之,当家族史为总体卵巢癌时,估计特定组织学的卵巢癌的 RR。在仅母亲、仅姐妹或母亲和姐妹均被诊断患有卵巢癌的家庭中,卵巢癌的风险分别为 2.40、2.59 和 10.40;50 岁前诊断的病例风险更高。除黏液性和性索-间质肿瘤外,所有组织学类型在双向分析中均显示出家族风险。在浆液性 (2.47)、子宫内膜样 (3.59) 和黏液性卵巢癌中发现了一致组织学的 RR。在一致性家族风险中,黏液性癌最高;对于其他类型,如子宫内膜样-未分化 (9.27) 和浆液性-未分化 (4.80),则显示出最高的 RR。家族风险对于早发性患者和有多个受累亲属的患者较高。不同组织学类型的卵巢癌的共享可能表明潜在机制的复杂性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc5/6169923/5a11bbc063be/pone.0205000.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc5/6169923/5a11bbc063be/pone.0205000.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc5/6169923/5a11bbc063be/pone.0205000.g001.jpg

相似文献

1
Familial risks of ovarian cancer by age at diagnosis, proband type and histology.按诊断时的年龄、先证者类型和组织学划分的卵巢癌的家族风险。
PLoS One. 2018 Oct 3;13(10):e0205000. doi: 10.1371/journal.pone.0205000. eCollection 2018.
2
Familial invasive and borderline ovarian tumors by proband status, age and histology.根据先证者状态、年龄和组织学分类的家族性侵袭性和交界性卵巢肿瘤
Int J Cancer. 2003 Jul 10;105(5):701-5. doi: 10.1002/ijc.11151.
3
Familial clustering of ovarian and endometrial cancers.卵巢癌和子宫内膜癌的家族聚集性。
Eur J Cancer. 2004 Jan;40(1):90-5. doi: 10.1016/s0959-8049(03)00627-0.
4
Familial association of specific histologic types of ovarian malignancy with other malignancies.卵巢恶性肿瘤特定组织学类型与其他恶性肿瘤的家族性关联。
Cancer. 2004 Apr 1;100(7):1507-14. doi: 10.1002/cncr.20138.
5
Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.基于组织学类型和诊断时年龄的睾丸癌患者亲属的癌症风险:来自五个北欧国家的联合研究。
Eur Urol. 2015 Aug;68(2):283-9. doi: 10.1016/j.eururo.2014.12.031. Epub 2015 Apr 23.
6
Familial melanoma by histology and age: joint data from five Nordic countries.组织学和年龄相关的家族性黑色素瘤:来自五个北欧国家的联合数据。
Eur J Cancer. 2014 Apr;50(6):1176-83. doi: 10.1016/j.ejca.2013.12.023. Epub 2014 Jan 21.
7
Familial risk of cancer by site and histopathology.按部位和组织病理学划分的癌症家族风险。
Int J Cancer. 2003 Jan 1;103(1):105-9. doi: 10.1002/ijc.10764.
8
Concordant and discordant familial cancer: Familial risks, proportions and population impact.一致性和不一致性家族性癌症:家族风险、比例及对人群的影响。
Int J Cancer. 2017 Apr 1;140(7):1510-1516. doi: 10.1002/ijc.30583. Epub 2017 Jan 20.
9
Incidence and mortality in epithelial ovarian cancer by family history of any cancer.根据任何癌症的家族史,上皮性卵巢癌的发病率和死亡率。
Cancer. 2011 Sep 1;117(17):3972-80. doi: 10.1002/cncr.26016. Epub 2011 Mar 1.
10
Familial Ovarian Cancer Clusters with Other Cancers.家族性卵巢癌与其他癌症的聚集性。
Sci Rep. 2018 Aug 1;8(1):11561. doi: 10.1038/s41598-018-29888-4.

引用本文的文献

1
Epidemiological and clinicopathological characteristics of ovarian cancer in Syria during the war years: a national multicenter retrospective study (2017-2021).叙利亚战争期间卵巢癌的流行病学和临床病理特征:一项全国多中心回顾性研究(2017 - 2021年)
BMC Cancer. 2025 Aug 22;25(1):1359. doi: 10.1186/s12885-025-14784-8.
2
Expression of cyclooxygenase-2 (COX-2) in epithelial ovarian cancers in an Indigenous African population of Kano, Nigeria.尼日利亚卡诺州非洲原住民人群上皮性卵巢癌中环氧合酶-2(COX-2)的表达
Ecancermedicalscience. 2025 Feb 5;19:1838. doi: 10.3332/ecancer.2025.1838. eCollection 2025.
3
Beyond the BRCA1/2 genes in ovarian cancer: the role of germline pathogenic variants in the ATM gene.

本文引用的文献

1
Global Cancer in Women: Burden and Trends.全球女性癌症:负担与趋势
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457. doi: 10.1158/1055-9965.EPI-16-0858. Epub 2017 Feb 21.
2
Concordant and discordant familial cancer: Familial risks, proportions and population impact.一致性和不一致性家族性癌症:家族风险、比例及对人群的影响。
Int J Cancer. 2017 Apr 1;140(7):1510-1516. doi: 10.1002/ijc.30583. Epub 2017 Jan 20.
3
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
卵巢癌中BRCA1/2基因之外:种系致病性变异在ATM基因中的作用。
Mol Biol Rep. 2025 Feb 21;52(1):261. doi: 10.1007/s11033-025-10357-x.
4
Reversible downregulation of MYC in a spheroid model of metastatic epithelial ovarian cancer.转移性上皮性卵巢癌球体模型中MYC的可逆性下调
Cancer Gene Ther. 2025 Jan;32(1):83-94. doi: 10.1038/s41417-024-00850-z. Epub 2024 Nov 21.
5
A Comprehensive Review of Screening Methods for Ovarian Masses: Towards Earlier Detection.卵巢肿物筛查方法的全面综述:迈向早期检测
Cureus. 2023 Nov 8;15(11):e48534. doi: 10.7759/cureus.48534. eCollection 2023 Nov.
6
Clinicopathological Parameters Associated With Peritoneal Involvement in Epithelial Ovarian Tumors.上皮性卵巢肿瘤腹膜受累相关的临床病理参数
Cureus. 2023 Mar 25;15(3):e36666. doi: 10.7759/cureus.36666. eCollection 2023 Mar.
7
Long-term risk of cancer among the first-degree relatives of epithelial ovarian cancer patients: A cohort study with 48 years of follow up.上皮性卵巢癌患者一级亲属的长期癌症风险:一项随访 48 年的队列研究。
Acta Obstet Gynecol Scand. 2023 Mar;102(3):240-245. doi: 10.1111/aogs.14504. Epub 2023 Jan 16.
8
Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer.基于纳米技术的核酸疫苗治疗卵巢癌。
Pharm Res. 2023 Jan;40(1):123-144. doi: 10.1007/s11095-022-03434-4. Epub 2022 Nov 14.
9
Klotho promoter methylation status and its prognostic value in ovarian cancer.Klotho基因启动子甲基化状态及其在卵巢癌中的预后价值。
Mol Clin Oncol. 2021 Sep;15(3):181. doi: 10.3892/mco.2021.2343. Epub 2021 Jul 3.
10
Death of 43 Indonesian women with ovarian cancer: A case series.43例印度尼西亚卵巢癌女性患者死亡情况:病例系列报道
Int J Surg Case Rep. 2021 Jan;78:391-396. doi: 10.1016/j.ijscr.2020.12.067. Epub 2020 Dec 24.
按组织学亚型分类的卵巢癌风险因素:来自卵巢癌队列联盟的分析
J Clin Oncol. 2016 Aug 20;34(24):2888-98. doi: 10.1200/JCO.2016.66.8178. Epub 2016 Jun 20.
4
Inherited Mutations in Women With Ovarian Carcinoma.遗传性突变与卵巢癌女性。
JAMA Oncol. 2016 Apr;2(4):482-90. doi: 10.1001/jamaoncol.2015.5495.
5
Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.1999年至2012年韩国上皮性卵巢癌按组织学亚型划分的发病率
J Gynecol Oncol. 2016 Jan;27(1):e5. doi: 10.3802/jgo.2016.27.e5. Epub 2015 Dec 1.
6
Why have ovarian cancer mortality rates declined? Part I. Incidence.卵巢癌死亡率为何下降?第一部分。发病率。
Gynecol Oncol. 2015 Sep;138(3):741-9. doi: 10.1016/j.ygyno.2015.06.017. Epub 2015 Jun 14.
7
Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants.按肿瘤亚型和已知的卵巢癌遗传易感性变异划分的卵巢癌家族相对风险
J Med Genet. 2014 Feb;51(2):108-13. doi: 10.1136/jmedgenet-2013-102015. Epub 2013 Nov 25.
8
Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype.识别卵巢癌患者中的林奇综合征:肿瘤亚型的意义。
Adv Anat Pathol. 2013 Nov;20(6):378-86. doi: 10.1097/PAP.0b013e3182a92cf8.
9
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.BRCA1 和 BRCA2 突变携带者的癌症风险:EMBRACE 前瞻性分析的结果。
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22. doi: 10.1093/jnci/djt095. Epub 2013 Apr 29.
10
Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer.基于人群的卵巢癌女性错配修复基因突变频率研究。
Br J Cancer. 2012 Nov 6;107(10):1783-90. doi: 10.1038/bjc.2012.452. Epub 2012 Oct 9.